Combination treatment of transcatheter arterial chemoembolization, intensity-modulated radiotherapy, and sorafenib for hepatocellular carcinoma with macrovascular invasion.

Yang, Dan; Du, Jiaojiao; Nie, Weijie; Wang, Chaozhi; Ma, Zhufang

Yang, Dan; Du, Jiaojiao; Nie, Weijie; Wang, Chaozhi; Ma, Zhufang.

Affiliation

Yang D; Department of Gastroenterology, 3201 Hospital, Hanzhong, China.

Medicine (Baltimore) ; 102(45): e35713, 2023 Nov 10.

Article in En | MEDLINE | ID: mdl-37960807

Subject(s)

Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Liver Neoplasms; Radiotherapy, Intensity-Modulated; Humans; Carcinoma, Hepatocellular/pathology; Sorafenib/therapeutic use; Radiotherapy, Intensity-Modulated/adverse effects; Liver Neoplasms/pathology; Retrospective Studies; Chemoembolization, Therapeutic/adverse effects; Antineoplastic Agents/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Chemoembolization, Therapeutic / Carcinoma, Hepatocellular / Radiotherapy, Intensity-Modulated / Liver Neoplasms / Antineoplastic Agents Language: En Journal: Medicine (Baltimore) Year: 2023 Type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google